NLRP3 and melanoma: Notably, this analysis highlighted a strong correlation between NLRP3 expression and patient survival, especially in melanoma and hepatocellular carcinoma, where higher NLRP3 levels were linked to improved survival rates, a more favorable prognosis, and enhanced responses to immunotherapy.